To investigate the potential role of PAC in inhibiting the AKT/mTOR pathway in thyroid cancer cells, CAL-62 cells were either sham-treated or exposed to PAC (10 μM), and then were harvested at different periods of time (24, 48 and 72 h). This evidence concerns the gene AKT1 and thyroid cancer.